Uterine artery embolisation ‘yields durable results’ in adenomyosis
The procedure should be offered routinely to women who fail conservative therapies, gynaecologists say
Four out of five women who have uterine artery embolisation (UAE) for symptomatic adenomyosis will have no recurrence of pain and heavy bleeding for years postprocedure, a study shows.
Sydney doctors carried out extended follow-up of earlier research tracking 117 women (mean age 45) who had UAE for symptomatic adenomyosis performed by one doctor operating at a single Sydney hospital between 2008 and 2015.
At a median follow-up of 18 months, the procedure was found to be successful in 104 (90%) of the women.
In the new study, two interventional radiologists and a gynaecologist followed up the patients again at a median of 50 months to determine durability of the response.
